Literature DB >> 31343073

Immune cell trafficking to the islets during type 1 diabetes.

A M Sandor1,2, J Jacobelli1,2, R S Friedman1,2.   

Abstract

Inhibition of immune cell trafficking to the pancreatic islets during type 1 diabetes (T1D) has therapeutic potential, since targeting of T cell and B cell trafficking has been clinically effective in other autoimmune diseases. Trafficking to the islets is characterized by redundancy in adhesion molecule and chemokine usage, which has not enabled effective targeting to date. Additionally, cognate antigen is not consistently required for T cell entry into the islets throughout the progression of disease. However, myeloid cells are required to enable T cell and B cell entry into the islets, and may serve as a convergence point in the pathways controlling this process. In this review we describe current knowledge of the factors that mediate immune cell trafficking to pancreatic islets during T1D progression.
© 2019 British Society for Immunology.

Entities:  

Keywords:  adhesion molecules; autoimmunity; cell trafficking; chemokines; diabetes

Mesh：

Year:  2019        PMID： 31343073      PMCID： PMC6857188          DOI： 10.1111/cei.13353

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  109 in total

1.  In vivo analysis of uropod function during physiological T cell trafficking.

Authors:  Silvia F Soriano; Miroslav Hons; Kathrin Schumann; Varsha Kumar; Timo J Dennier; Ruth Lyck; Michael Sixt; Jens V Stein
Journal:  J Immunol       Date:  2011-07-27       Impact factor: 5.422

2.  The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes.

Authors:  E Aboumrad; A M Madec; C Thivolet
Journal:  Clin Exp Immunol       Date:  2007-03-21       Impact factor: 4.330

3.  Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes.

Authors:  Barbara Glowinska; Miroslawa Urban; Jadwiga Peczynska; Bozena Florys
Journal:  Metabolism       Date:  2005-08       Impact factor: 8.694

4.  Population dynamics of islet-infiltrating cells in autoimmune diabetes.

Authors:  Angela M Magnuson; Greg M Thurber; Rainer H Kohler; Ralph Weissleder; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

Review 5.  CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.

Authors:  Magda Kucia; Kacper Jankowski; Ryan Reca; Marcin Wysoczynski; Laura Bandura; Daniel J Allendorf; Jin Zhang; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

6.  Molecular genetic analysis of the Idd4 locus implicates the IFN response in type 1 diabetes susceptibility in nonobese diabetic mice.

Authors:  Evgueni A Ivakine; Omid M Gulban; Steven M Mortin-Toth; Ellen Wankiewicz; Christopher Scott; David Spurrell; Angelo Canty; Jayne S Danska
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

7.  Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant.

Authors:  D V Serreze; E H Leiter; G J Christianson; D Greiner; D C Roopenian
Journal:  Diabetes       Date:  1994-03       Impact factor: 9.461

8.  The pathogenesis of adoptive murine autoimmune diabetes requires an interaction between alpha 4-integrins and vascular cell adhesion molecule-1.

Authors:  J L Baron; E P Reich; I Visintin; C A Janeway
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

Review 9.  T lymphocyte trafficking: molecules and mechanisms.

Authors:  Hongmei Fu; Amu Wang; Claudio Mauro; Federica Marelli-Berg
Journal:  Front Biosci (Landmark Ed)       Date:  2013-01-01

10.  Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells.

Authors:  Alexei Y Savinov; F Susan Wong; Austin C Stonebraker; Alexander V Chervonsky
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307
View more
  12 in total

Review 1.  Autoimmunity in motion: Mechanisms of immune regulation and destruction revealed by in vivo imaging.

Authors:  Jordan Jacobelli; Alan E Buser; Dustin L Heiden; Rachel S Friedman
Journal:  Immunol Rev       Date:  2021-11-25       Impact factor: 10.983

2.  Historical and new insights into pathogenesis of type 1 diabetes (2).

Authors:  F S Wong; T I Tree
Journal:  Clin Exp Immunol       Date:  2021-05       Impact factor: 4.330

3.  Insulin Receptor-Expressing T Cells Appear in Individuals at Risk for Type 1 Diabetes and Can Move into the Pancreas in C57BL/6 Transgenic Mice.

Authors:  Neha Nandedkar-Kulkarni; Emily Esakov; Brigid Gregg; Mark A Atkinson; Douglas G Rogers; James D Horner; Kanakadurga Singer; Steven K Lundy; Jamie L Felton; Tasneem Al-Huniti; Andrea Nestor Kalinoski; Michael P Morran; Nirdesh K Gupta; James D Bretz; Swapnaa Balaji; Tian Chen; Marcia F McInerney
Journal:  J Immunol       Date:  2021-03-03       Impact factor: 5.422

4.  Historical and new insights into pathogenesis of type 1 diabetes.

Authors:  F S Wong; T I Tree
Journal:  Clin Exp Immunol       Date:  2019-12       Impact factor: 4.330

Review 5.  Evolving Antibody Therapies for the Treatment of Type 1 Diabetes.

Authors:  Qi Ke; Charles J Kroger; Matthew Clark; Roland M Tisch
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

6.  The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD Mice.

Authors:  Tingting Ge; Gaurang Jhala; Stacey Fynch; Satoru Akazawa; Sara Litwak; Evan G Pappas; Tara Catterall; Ishan Vakil; Andrew J Long; Lisa M Olson; Balasubramanian Krishnamurthy; Thomas W Kay; Helen E Thomas
Journal:  Front Immunol       Date:  2020-12-04       Impact factor: 7.561

7.  Recombinant Lactococcus lactis Carrying IL-4 and IL-10 Coding Vectors Protects against Type 1 Diabetes in NOD Mice and Attenuates Insulitis in the STZ-Induced Model.

Authors:  Tatiane M Preisser; Vanessa P da Cunha; Mariana P Santana; Vanessa B Pereira; Denise C Cara; Bianca M Souza; Anderson Miyoshi
Journal:  J Diabetes Res       Date:  2021-02-02       Impact factor: 4.011

Review 8.  Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.

Authors:  Urs Christen; Ruta Kimmel
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-19       Impact factor: 5.555

9.  Molecular Footprints of the Immune Assault on Pancreatic Beta Cells in Type 1 Diabetes.

Authors:  Maikel L Colli; Florian Szymczak; Decio L Eizirik
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-15       Impact factor: 5.555

10.  3D quantification of changes in pancreatic islets in mouse models of diabetes type I and II.

Authors:  Urmas Roostalu; Jacob Lercke Skytte; Casper Gravesen Salinas; Thomas Klein; Niels Vrang; Jacob Jelsing; Jacob Hecksher-Sørensen
Journal:  Dis Model Mech       Date:  2020-12-18       Impact factor: 5.758
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.